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Abstract: The ketogenic diet (KD), a restrictive diet, is mainly characterized by high-fat content, low or no 
carbohydrate content, and low or normal protein content. This review aimed to address the main syndromes or 
diseases in which the therapeutic use of KD can be beneficial. One of the main clinical indications of KD has been, 
for some time, in the treatment of epilepsy refractory to the use of medications, with satisfactory results in the 
control of seizures. Recently, studies have addressed the metabolism of ketone bodies caused by KD, in the adjuvant 
treatment of tumors and endocrine disorders, such as diabetes and obesity, with promising results. In this work, the 
therapeutic aspect of KD was analyzed, as an aid in the control of pre-existing diseases, and that being a very 
restrictive diet with controversial effects, its use may be limited and it is not advisable to maintain it for long periods 
or without the proper follow-up. 
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Introduction 
 The use of the ketogenic diet (KD) was 
introduced into clinical practice in the 1920s, although 
there are reports of ketogenic medicine since ancient 
Greece. KD consists of high-fat content, low or no 
carbohydrate content, and low or normal protein 
content [1]. Despite being a special and therapeutic 
diet, it must meet the general principles of nutrition and 
provide the body with energy, proteins, minerals, and 
vitamins, even though supplements, aiming at the 
development and maintenance of the patient's 
physiological conditions [2]. 
 Classic DC is typically composed of a 4:1 
macronutrient ratio (4 g fat for every 1 g protein plus 
carbohydrate combined), thus shifting the predominant 
caloric source from carbohydrate to fat. Lower fat ratios 
(3:1; 2:1; 1:1), termed modified DC, can be used 
depending on the patient's age, tolerance, ketosis level, 
and protein requirement. To increase flexibility and 
adaptability, “easier” variants have been developed, 
including the modified Atkins diet, the low glycemic 
index diet, and the ketogenic diet combined with oil of 
medium-chain triglycerides (MCT) [3-5]. 
 Chronic ingestion of high amounts of fats with 
low carbohydrate content causes changes in liver 
metabolism similar to what happens during periods of 
fasting, with increased lipolysis, gluconeogenesis, and 
synthesis of ketone bodies [3]. Due to the decrease of 
 carbohydrates in the body, the energy in KD is 
mainly derived from the oxidation processes of fatty 
acids in the mitochondria, which generate large 
amounts of acetyl-CoA and lead to a reduction in the 
metabolic efficiency of the Krebs cycle and the diversion 
of excess of acetyl-CoA for the production of ketone 
bodies [1]. The generated ketone bodies, acetoacetate, 
and β-hydroxybutyrate enter the bloodstream and reach 
the organs, including the central nervous system (CNS), 
where they are used as a source of energy, and the 
acetone produced by the decarboxylation of 
acetoacetate, being volatile, is rapidly eliminated 
through the lungs and urine [3]. 
 The use of this type of diet for weight loss and 
its effect on long-term mortality is controversial, as 
recently shown [6], and may depend on the source of 
replacement of dietary carbohydrate with fat and plant-
based or animal-based protein. As for its therapeutic 
use, the KD has been successfully used to control drug-
resistant epileptic seizures, and currently, several 
epileptic syndromes and other anomalies in which KD 
can be particularly beneficial are described in the 
literature [7]. 
 Thus, this review aimed to address the main 
therapeutic indications in which the use of KD has 
shown satisfactory results. 
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Methods 
Study Design 
 The present study followed a integrative review 
model, following the rules of systematic review - 




Search Strategy and Information Sources 
 The search strategy was carried out in the 
PubMed, Cochrane Library and Scopus databases, as 
well as Google Scholar in the search for doctoral and 
master's theses, using scientific articles from 1978 to 
2021, using the descriptors Ketogenic diet. Epilepsy. 
Cancer. Obesity. Diabetes, and use of the Booleans 
"and" between MeSH Terms and "or" among historical 
findings. 
 
Study Quality and Bias Risk 
 Quality was classified as high, moderate, low, 
or very low to the risk of bias, clarity of comparisons, 
precision, and consistency of the analyzes. The most 
evident highlight was for systematic review articles or 
meta-analysis of randomized clinical trials, followed by 
randomized controlled trials. The low quality of evidence 
was attributed to case reports, editorials, and brief 
communications, according to the GRADE instrument 
[9]. The risk of bias was analyzed according to the 
Cochrane instrument [10]. 
 
Results 
 As a corollary to the literary search system, a 
total of 105 studies were compared that were submitted 
to the eligibility analysis and, after that, 28 studies of 
high to medium quality were selected, considering in the 
first instance the level of scientific evidence of studies in 
type of study as meta-analysis, randomized, prospective 
and observational. The biases risk not compromising the 
scientific basis of the studies. 
 
The Ketogenic Diet in Epilepsy 
 Epilepsy is a neurological disorder characterized 
by recurrent epileptic seizures that often lead to 
cognitive deficits. It is characterized by disturbances in 
the functioning of the neuronal circuitry, resulting from 
excessive and sudden neuronal discharges with 
heterogeneous clinical manifestations and with various 
etiologies [11]. Epilepsy affects a large number of 
individuals, being one of the most serious and frequent 
neurological disorders in the pediatric age [12]. 
Approximately one-third of epileptic patients progress to 
a more severe condition with intractable epilepsy from 
a drug point of view, crises that are not controlled by 
maximum tolerated doses of 2 or 3 antiepileptic drugs, 
requiring the use of more invasive alternative 
treatments, such as a surgical procedure [2,7]. 
Refractory epileptic seizures represent a threat to the 
child, due to the increased risk of accidents and 
mortality, secondary malnutrition, with consequent 
damage and delay in physical and cognitive 
development, resulting from the disease and therapy, 
whose effectiveness is not as achieved [7,13]. 
 Parallel to and regardless of the medication 
used, it was observed that epileptic patients had better 
seizure control when fasting or in the presence of 
metabolic acidosis resulting from prolonged fasting, and 
thus, the KD has been increasingly used in the 
treatment of epilepsy refractory to use of medications 
[14]. Glucose is normally the only fuel for the human 
CNS since the blood-brain barrier prevents the passage 
of fatty acids and makes its use as an energy source 
impossible. In contrast, ketone bodies enter the brain in 
proportion to the increase in serum ketosis levels, 
although under normal metabolic conditions ketone 
bodies are not utilized by nerve cells. During the use of 
KD, however, ketone bodies partially replace glucose as 
fuel for the brain [1,15]. 
 The mechanism of action by which KD leads to 
the reduction of epileptic seizures is still unclear. It is 
suggested that the excessive supply of fat together with 
the reduction in the supply of carbohydrates can 
maintain the metabolic mechanism of starvation, a 
situation in which lipids are used as an energy source, 
maintaining a state of ketosis. The sedative effect of 
ketone bodies, their concentration in plasma, the degree 
of acidosis, partial dehydration, marked changes in lipid 
concentration and the metabolic adaptation of the brain 
resulting from ketosis would be the main factors 
responsible for controlling the attacks [2]. It is further 
suggested that a fundamental shift from glycolysis to 
DC-induced intermediary metabolism is necessary and 
sufficient for clinical efficacy. This hypothesis is 
supported by an exponential number of studies 
indicating that together, polyunsaturated fatty acids, 
ketone bodies, and glucose restriction may play 
mechanistic roles possibly by increasing ATP production, 
mitochondrial respiration, and decreasing reactive 
oxygen production. Another anticonvulsant mechanism 
triggered by KD involves an increased synthesis of 
gamma-aminobutyric acid (GABA). Metabolism via 
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ketosis would provide an increase in this 
neurotransmitter, decreasing the rate of epileptic 
seizures [16]. 
 In recent years, the effectiveness of KD has 
been evaluated using the original research and 
evaluation system, which showed that diet was an 
effective and well-tolerated treatment for refractory 
childhood epilepsy [17]. These results have boosted 
interest in KD as a treatment for intractable epilepsy for 
adults as well. Recently, a meta-analysis study analyzed 
findings from published studies relevant to identifying 
the efficacy of KD for the treatment of intractable 
epilepsy in adults. A study of more than 402 articles was 
performed and the results of this meta-analysis showed 
the effectiveness of KD in the complete absence of 
seizures, in reducing seizures by 50% or more, and 
reducing seizures by less than 50% in adults with drug-
intractable epilepsy were 13%, 53%, and 27%, 
respectively [18]. 
 This same study also evaluated the adverse 
reactions arising from the use of KD in patients with 
difficult-to-control epilepsy. The results showed that the 
adverse reactions of classic KD were mild, while the 
glycemic index diet and diet with low fish oil content 
may have even fewer adverse effects, including weight 
loss, high level of low-density lipoprotein and high total 
cholesterol were the most frequent. In the child 
population, one should be aware of possible 
micronutrient deficiencies and the growth curve due to 
food restriction. 
 Thus, this meta-analysis study [18] indicated 
that the use of KD for refractory epilepsy in adults can 
be a well-tolerated treatment and that its side effects 
are acceptable, showing that the therapeutic use of KD 
is a promising treatment. in intractable epilepsy also in 
adults. 
 Patients with epilepsy may present, among 
other impairments, cognitive deficits. Cognition 
deficiencies are likely caused due to complex 
interactions between epileptic seizures, brain damage, 
and harmful effects of drug treatment. The severity of 
cognitive problems depends on the age of onset of 
epilepsy, etiology, type of epileptic seizure, and use of 
medication. 
 Thus, patients with frequent and chronic 
seizures with drug overuse are particularly affected by 
cognitive problems. Recently, a review study with a 
systematic approach [19] was carried out to evaluate 
the effects on cognition after the treatment of KD in 
adults and children with frequent epileptic seizures. This 
study showed that using subjective assessments of 
patient experience, cognitive improvements were 
frequently reported during KD treatment in the domains 
of attention, attention, and global cognition; in addition, 
neuropsychological tests confirmed dietary benefits on 
alertness but found no improvement in global cognition. 
There was also evidence that these improvements are 
caused by both the reduction in seizures and the direct 
effects of KD on cognition. 
 Thus, the use of KD in the control of drug-
resistant epilepsy proved to be beneficial by reducing 
the number of seizures, tolerable adverse effects, and 
with good results on the cognitive aspects of pediatric 
and adult patients with epilepsy [15]. 
 
Ketogenic Diet and Cancer 
 Dietary restriction from KD reduces plasma 
glucose levels and limits the energy supply to some cells 
while increasing circulating blood ketone levels [1]. KD 
also imposes on cells that they depend on fat oxidation 
and mitochondrial respiration, compared to glycolysis 
for energy production, since carbohydrates are 
unavailable. Regarding these characteristics of KD-
derived metabolism, these dietary modifications can be 
expected to decrease tumor size and growth rate that 
depend on glucose as an energy source during 
anaerobic glycolysis. Furthermore, other metabolic 
changes found in malignant cells are related to the 
inability to metabolize ketone bodies due to various 
deficiencies in mitochondrial enzymes [20]. Thus, due 
to the state of ketosis combined with the absence of 
glucose provided by KD and in addition to the 
discoveries of malignant cell metabolism, the 
perspectives for the therapeutic use of anti-tumor KD 
have increased considerably [21]. 
 Recently, a systematic review was carried out 
to evaluate the effects of KD on the growth and survival 
time of tumor cells in animal studies [22]. All studies 
included in this review indicated that KD exhibited an 
inhibitory effect on tumor growth and nine studies 
indicated that KD could increase survival time. Tumor 
types included pancreas, stomach, colon, 
neuroblastoma, prostate, and lung cancer tumors. The 
authors of this study, therefore, concluded that 
although studies in this field are rare and inconsistent, 
recent findings have demonstrated that KD can 
potentially inhibit the growth of malignant cells and 
increase survival time and also that due to physiological 
differences between humans and animals, studies in 
humans they are necessary [22]. 
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Regarding recent advances in nutritional aspects of 
cancer therapy, a review was carried out focusing on 
the effects of dietary interventions, such as KD or 
fasting itself, on the metabolic pathways within cancer 
cells and the tumor environment (such as microbiota, 
system immune, and tumor microenvironment) involved 
in cancer progression and resistance, as well as cancer 
cell death [23]. This review demonstrated that a 
growing body of evidence has shown that nutrients can 
selectively sensitize malignant cells while protecting 
normal cells from their side effects. This modulation of 
nutrient supply through the diet may also improve 
immune cancer surveillance. Finally, based on the 
analysis of literature data, this study designed a 
nutritional intervention that consisted of a moderate 
ketogenic diet that could be beneficial and also explored 
for future preclinical research in cancer therapy [23]. 
Nutritional therapy does not replace any conventional 
treatment. 
 
Ketogenic Diet and Endocrine Disorders 
 Before the discovery of insulin, the KD was used 
as a way to avoid high blood sugar levels, which was 
inevitably fatal for type 1 diabetics. The favorable and 
beneficial effects of the therapeutic use of KD on caloric 
intake, body weight, lipid parameters, glycemic indexes, 
and insulin sensitivity make this dietary profile a 
therapeutic option in metabolic syndrome, obesity, and 
type 2 diabetes. In addition, several hormones such as 
insulin, glucagon, cortisol, catecholamines, and growth 
hormone also affect significantly the metabolism of 
ketone bodies. Based on this evidence, a review study 
was recently published regarding current perspectives 
on the use of KD in endocrine disorders [24]. 
 The analysis of studies on the perspective of the 
therapeutic use of KD in diabetes identified a strong 
relationship between the insulin resistance pathway and 
the metabolic state of ketosis. This study highlighted 
that element of lipid metabolism can facilitate the 
proper cellular localization of glucose transporters and 
their respective recycling, and KD can also alleviate 
certain inflammatory processes by blocking specific 
cytokines [25]. In addition, the KD is beneficial in 
improving glycemic control (glycated hemoglobin), 
reducing diabetic medications, increasing HDL 
cholesterol, and can promote weight loss in overweight 
and obese individuals with type 2 diabetes, as well as 
protein limitation and carbohydrates in KD may improve 
diabetic nephropathy [26]. 
 In obese patients, this same review study 
showed that the therapeutic use of KD can result in 
greater weight loss compared to other balanced diets 
[25]. He also highlighted that the possible mechanisms 
for greater weight loss may be due to the control of 
hunger and the greater satiety effect caused by KD. 
However, weight loss can also be linked only to the 
caloric deficit imposed by the diet. Previously, a study 
[27] observed that KD can significantly reduce serum 
levels of cholesterol, glucose and also decrease body 
weight, body mass index (BMI) and therefore reduce 
risk factors for various chronic diseases in obese 
hypercholesterolemic patients, if the replacement of 
carbohydrates is predominantly vegetable proteins and 
fats, it can be considered a long-term approach. A 
recent study suggests a long-term negative association 
between life expectancy and both low and high 
carbohydrate diets when dietary sources are not taken 
into account. These data provide further evidence that 
animal-based low-carbohydrate diets should be 
discouraged [6]. 
 In this context, therefore, the use of a ketogenic 
diet (KD) is recommended in the treatment of obesity 
and diabetes, as it has benefits in metabolic disorders, 
epileptic seizures, autosomal dominant polycystic 
disease of the kidney, cancers, peripheral neuropathy, 
and skeletal muscle atrophy. Many high-profile 
pathways are available for KD action, including 
sustaining metabolic actions on glucose sugar, 
suppressing insulin-like growth factor-1 (IGF1), and 
phosphoinositide 3-kinase (PI3K) / protein kinase B 
(AKT ) / mammal target of rapamycin pathways 
(mTOR). Thus, KD regulates the glucose and insulin 
sugar level and therefore can be considered an effective 
approach to diabetes [28]. 
 
Conclusion 
 This review study summarized the main and 
current clinical indications for the use of the ketogenic 
diet. The therapeutic use of this special type of diet has 
an important and known relevance in the treatment of 
epilepsies that are difficult to control with medication. 
In addition, this work showed the benefits of the 
metabolism of ketone bodies also in the supportive 
treatment of cancer, diabetes, and obesity, thus 
contributing to the updating of knowledge about the use 
of ketogenic diet in the therapy of diseases of great 
clinical and epidemiological importance. In the case of 
obese and diabetic patients, it is important to point out 
that due to lower consumption of fiber, and increased 
consumption of proteins (mainly of animal origin) and 
fat, the risk of heart disease, colon cancer, constipation 
is increased. In this work, the therapeutic aspect of the 
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diet was analyzed, as an aid in the control of pre-
existing diseases, and that being a very restrictive diet 
with controversial effects, its use may be limited and it 
is not advisable to maintain it for long periods or without 
the proper follow-up. As for its use for weight control, it 
can be said that the loss of body fat improves several 
risk factors (decrease in visceral fat, decrease in blood 
pressure, improvement in cholesterol and blood sugar 
levels), having been proven in several interventions’ 
studies. The important thing is to have a diet that allows 
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